BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 10213692)

  • 1. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1.
    Skowyra D; Koepp DM; Kamura T; Conrad MN; Conaway RC; Conaway JW; Elledge SJ; Harper JW
    Science; 1999 Apr; 284(5414):662-5. PubMed ID: 10213692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast.
    Patton EE; Willems AR; Sa D; Kuras L; Thomas D; Craig KL; Tyers M
    Genes Dev; 1998 Mar; 12(5):692-705. PubMed ID: 9499404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2.
    Kamura T; Conrad MN; Yan Q; Conaway RC; Conaway JW
    Genes Dev; 1999 Nov; 13(22):2928-33. PubMed ID: 10579999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34.
    Seol JH; Feldman RM; Zachariae W; Shevchenko A; Correll CC; Lyapina S; Chi Y; Galova M; Claypool J; Sandmeyer S; Nasmyth K; Deshaies RJ; Shevchenko A; Deshaies RJ
    Genes Dev; 1999 Jun; 13(12):1614-26. PubMed ID: 10385629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase.
    Kamura T; Koepp DM; Conrad MN; Skowyra D; Moreland RJ; Iliopoulos O; Lane WS; Kaelin WG; Elledge SJ; Conaway RC; Harper JW; Conaway JW
    Science; 1999 Apr; 284(5414):657-61. PubMed ID: 10213691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex.
    Skowyra D; Craig KL; Tyers M; Elledge SJ; Harper JW
    Cell; 1997 Oct; 91(2):209-19. PubMed ID: 9346238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCF ubiquitin protein ligases and phosphorylation-dependent proteolysis.
    Willems AR; Goh T; Taylor L; Chernushevich I; Shevchenko A; Tyers M
    Philos Trans R Soc Lond B Biol Sci; 1999 Sep; 354(1389):1533-50. PubMed ID: 10582239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway.
    Willems AR; Lanker S; Patton EE; Craig KL; Nason TF; Mathias N; Kobayashi R; Wittenberg C; Tyers M
    Cell; 1996 Aug; 86(3):453-63. PubMed ID: 8756727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferable domain in the G(1) cyclin Cln2 sufficient to switch degradation of Sic1 from the E3 ubiquitin ligase SCF(Cdc4) to SCF(Grr1).
    Berset C; Griac P; Tempel R; La Rue J; Wittenberg C; Lanker S
    Mol Cell Biol; 2002 Jul; 22(13):4463-76. PubMed ID: 12052857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases.
    Zhou P; Howley PM
    Mol Cell; 1998 Nov; 2(5):571-80. PubMed ID: 9844630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdc34 and the F-box protein Met30 are required for degradation of the Cdk-inhibitory kinase Swe1.
    Kaiser P; Sia RA; Bardes EG; Lew DJ; Reed SI
    Genes Dev; 1998 Aug; 12(16):2587-97. PubMed ID: 9716410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases.
    Ohta T; Xiong Y
    Cancer Res; 2001 Feb; 61(4):1347-53. PubMed ID: 11245432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grr1 functions in the ubiquitin pathway in Saccharomyces cerevisiae through association with Skp1.
    Kishi T; Seno T; Yamao F
    Mol Gen Genet; 1998 Jan; 257(2):143-8. PubMed ID: 9491072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIC1 is ubiquitinated in vitro by a pathway that requires CDC4, CDC34, and cyclin/CDK activities.
    Verma R; Feldman RM; Deshaies RJ
    Mol Biol Cell; 1997 Aug; 8(8):1427-37. PubMed ID: 9285816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation.
    Wu K; Fuchs SY; Chen A; Tan P; Gomez C; Ronai Z; Pan ZQ
    Mol Cell Biol; 2000 Feb; 20(4):1382-93. PubMed ID: 10648623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4.
    Kaiser P; Flick K; Wittenberg C; Reed SI
    Cell; 2000 Aug; 102(3):303-14. PubMed ID: 10975521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
    Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
    EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box (SCF)-mediated ubiquitination and cell cycle progression.
    Sadowski M; Mawson A; Baker R; Sarcevic B
    Biochem J; 2007 Aug; 405(3):569-81. PubMed ID: 17461777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
    Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M
    Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components of an SCF ubiquitin ligase localize to the centrosome and regulate the centrosome duplication cycle.
    Freed E; Lacey KR; Huie P; Lyapina SA; Deshaies RJ; Stearns T; Jackson PK
    Genes Dev; 1999 Sep; 13(17):2242-57. PubMed ID: 10485847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.